Transgender People with HIV Section Added to Adult/Adolescent ARV Guidelines
A new section, Transgender People with HIV, has been added to the latest update to the Guidelines for the Use of Antiretroviral Agents in Adults and Adolescents with HIV, released July 10. The What's New summary provides highlights to this addition to the Special Populations section and reads as follows:
Transgender and nonbinary people bear a disproportionate burden of HIV. According to the most recent estimate, 14% of transgender women have HIV and 2% of transgender men have HIV. To address the specific HIV care needs of these individuals, the Panel on Antiretroviral Guidelines for Adults and Adolescents (the Panel) has created a new section of the guidelines. This section focuses on:
The importance of providing HIV care services within a gender-affirmative care model to reduce potential barriers to antiretroviral therapy (ART) adherence and maximize the likelihood of achieving sustained viral suppression;
The role of gender-affirming hormonal therapy and the potential interactions between these drugs and certain antiretroviral (ARV) drugs; and
Potential health impacts of gender-affirming hormonal therapy on transgender persons with HIV.
See our resources on transgender people with HIV